These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 32808846

  • 1. CRNDE mediates the viability and epithelial-mesenchymal transition of renal cell carcinoma via miR-136-5p.
    Zhang Y, Lan X, Wang Y, Liu C, Cui T.
    J Recept Signal Transduct Res; 2021 Jun; 41(3):234-244. PubMed ID: 32808846
    [Abstract] [Full Text] [Related]

  • 2. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H, Kong J, Ding K, Shen HM, Wu H, Xia D, Wu Y.
    Mol Cancer; 2017 Jul 11; 16(1):118. PubMed ID: 28697764
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H, Ke J, Guo Q, Barnabo Nampoukime KP, Yang P, Ma K.
    J Cell Mol Med; 2018 Dec 11; 22(12):5862-5876. PubMed ID: 30246921
    [Abstract] [Full Text] [Related]

  • 4. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C, Zhang J.
    Biosci Rep; 2020 Nov 27; 40(11):. PubMed ID: 33185692
    [Abstract] [Full Text] [Related]

  • 5. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF, Li YC, Wang Y, Sun LB.
    Cell Physiol Biochem; 2018 Nov 27; 50(1):196-213. PubMed ID: 30278464
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
    Dasgupta P, Kulkarni P, Majid S, Shahryari V, Hashimoto Y, Bhat NS, Shiina M, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R.
    Mol Cancer Ther; 2018 May 27; 17(5):1061-1069. PubMed ID: 29440295
    [Abstract] [Full Text] [Related]

  • 7. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
    Li Z, Wu G, Li J, Wang Y, Ju X, Jiang W.
    BMC Cancer; 2020 Apr 06; 20(1):282. PubMed ID: 32252678
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
    Huang J, Yao X, Zhang J, Dong B, Chen Q, Xue W, Liu D, Huang Y.
    Cancer Sci; 2013 Dec 06; 104(12):1609-17. PubMed ID: 24112779
    [Abstract] [Full Text] [Related]

  • 9. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
    Liu H, Hu G, Wang Z, Liu Q, Zhang J, Chen Y, Huang Y, Xue W, Xu Y, Zhai W.
    Theranostics; 2020 Dec 06; 10(23):10791-10807. PubMed ID: 32929380
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R, Hu T, Liu Y, He Y, Cao Y.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 31912882
    [Abstract] [Full Text] [Related]

  • 11. Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p.
    Fu D, Zang L, Li Z, Fan C, Jiang H, Men T.
    Bioengineered; 2021 Dec 31; 12(1):2469-2479. PubMed ID: 34232111
    [Abstract] [Full Text] [Related]

  • 12. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H.
    Cancer Biol Ther; 2018 Jul 03; 19(7):573-583. PubMed ID: 29667486
    [Abstract] [Full Text] [Related]

  • 13. Pseudogene HSPB1P1 contributes to renal cell carcinoma proliferation and metastasis by targeting miR-296-5p to regulate HMGA1 expression.
    Chen Z, Wang Z, Chen Z, Fu F, Huang X, Huang Z.
    Cell Biol Int; 2021 Dec 03; 45(12):2479-2489. PubMed ID: 34431162
    [Abstract] [Full Text] [Related]

  • 14. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
    Guo M, Lin B, Li G, Lin J, Jiang X.
    J Recept Signal Transduct Res; 2020 Jun 03; 40(3):281-293. PubMed ID: 32106739
    [Abstract] [Full Text] [Related]

  • 15. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H, Enokida H, Itesako T, Tatarano S, Kinoshita T, Fuse M, Kojima S, Nakagawa M, Seki N.
    J Hum Genet; 2013 Aug 03; 58(8):508-16. PubMed ID: 23635949
    [Abstract] [Full Text] [Related]

  • 16. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z, Chang X, Zhu G, Gao X, Chang L.
    Cell Cycle; 2020 Aug 03; 19(16):2054-2062. PubMed ID: 32663095
    [Abstract] [Full Text] [Related]

  • 17. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
    Su Y, Zhou L, Yu Q, Lu J, Liu W.
    Technol Cancer Res Treat; 2021 Aug 03; 20():1533033821997834. PubMed ID: 33858283
    [Abstract] [Full Text] [Related]

  • 18. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
    Zhou S, Xu A, Song T, Gao F, Sun H, Kong X.
    Cancer Biother Radiopharm; 2020 Nov 03; 35(9):650-660. PubMed ID: 32186927
    [Abstract] [Full Text] [Related]

  • 19. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
    Wang K, Jin W, Song Y, Fei X.
    Mol Cancer; 2017 Oct 25; 16(1):166. PubMed ID: 29070041
    [Abstract] [Full Text] [Related]

  • 20. Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.
    Wang D, Zhu X, Siqin B, Ren C, Yi F.
    Toxicol Appl Pharmacol; 2022 Jul 15; 447():116067. PubMed ID: 35597301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.